US$ 21.03
combining glp-1 receptor agonist with dpp-4 inhibitor not recommended guideline DPP4 Inhibitors vs Agonists | June 2021 | Clinical Corner The Role of DPP-4 Inhibitors
Description
E.VendruscoloL

Gastrointestinal symptoms dominate

In clinical development, AI is helping to predict patient responses, streamline trial design, and identify optimal dosing strategies

Why does it work

[DOI] [PMC free article] [PubMed] [Google Scholar] 11.Aroda V.R., Bauer R., Christiansen E., Haluzk M., Kallenbach K., Montanya E., Rosenstock J., Meier J.J
